Table E.6Maintenance model: reimpaction failure rates and costs applied to the maintenance model

CodeReimpaction rateCost of reimpaction requiring treatmentMaintenance doseCost of remaining healthyCost of remaining healthy
3 months cost (£)Daily cost (£)3 months cost (£)Last 3 months before stopping (2 year period only; £)
PEG 3350 plus electrolytes baseline dose1010.2£9181p£72.92£36.46
PEG 3350 plus electrolytes higher dose1020.2£95.89£1.01£91.15£45.58
PEG 3350 plus electrolytes baseline dose followed by PEG 3350 plus electrolytes + sodium picosulfate1030.2£98.4586p£77.27£38.63
Picosulfate baseline dose2010.2£87.935p£4.34$32.17
Picosulfate higher dose2020.2£85.866p£5.43£32.71
Picosulfate baseline dose followed by PEG 3350 plus electrolytes + sodium picosulfate2030.2£88.4286p£77.27£38.63
Picosulfate baseline dose followed by picosulfate + senna2040.2£83.796p£5.25£2.63
Picosulfate baseline dose followed by picosulfate + lactulose2050.5£86.429p£7.89£3.95
Senna baseline dose3010.2£68.691p91p45p
Senna higher dose3020.2£47.381p£1.1357p
Senna baseline dose followed by picosulfate + senna3030.2£48.006p£5.25£32.63
Senna baseline dose followed by lactulose + senna3040.2£28.75p£4.46£2.23
Senna baseline dose followed by docusate + senna3050.2£30.966p£5.49£2.75
Methylcellulose6010.2n/a10p£8.65£4.32
Liquid paraffin light BP7010.5n/a6p£5.40£2.70
ACE8010.2n/a1p91p45p

From: Appendix E, Health economics

Cover of Constipation in Children and Young People
Constipation in Children and Young People: Diagnosis and Management of Idiopathic Childhood Constipation in Primary and Secondary Care.
NICE Clinical Guidelines, No. 99.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2010.
Copyright © 2010, National Collaborating Centre for Women's and Children's Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.